Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88- 91 studies

Blood

Volumn 92, Issue 3, 1998, Pages 795-801

  Putti, Maria Caterina ^a   Rondelli, Roberto ^b   Cocito, Maria Grazia ^b   Aricó, Maurizio ^b   Sainati, Laura ^b   Conter, Valentine ^b   Guglielmi, Cesare ^b   Cantú Rajnoldi, Angelo ^b   Consolini, Rita ^b   Pession, Andrea ^b   Zanesco, Luigi ^b   Masera, Giuseppe ^b   Biondi, Andrea ^b   Basso, Giuseppe ^b  

^a Dipartimento di Pediatria   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; FEMALE; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032147024     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.795.415k01_795_801     Document Type: Article

References (51)

1. Pui C-H, Behm FG, Crist WM: Clinical and biologic relevance of immunologie marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
2. Pui C-H, Crist WM: Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491, 1994
3. Reiter A, Schrappe M, Ludwig W-D, Hiddeman W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H: Chemotherapy in 988 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM86. Blood 84:3122, 1994
4. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE: Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute - Children Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol 12:740, 1994
5. Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui C-H, Crist WM, Look AT, Rivera GK: Cytogenetics of pre-B acute lymphoblastic leukemia with emphasis on prognostic implications of the t(l;19). J Clin Oncol 8:1380, 1990
6. Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1, 1986
7. Pui C-H, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP, Behm FG, Borowitz MJ: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 77:440, 1991
8. Pui C-H, Crist WM, Look AT: Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76: 1449, 1990
9. Crist WM, Carrol A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A, Hirt A, Brock B, Land V, Pullen J: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489, 1990
10. Drexler HG, Thiel E, Ludwig W-D: Review of the incidence and clinical importance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5:637, 1991
11. Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD: Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316:1111,1987
12. Childs CC, Hirsch-Ginsberg C, Walters RS, Andersson BS, Reuben J, Trujillo JM, Cork A, Stass SA, Freireich EJ, Zipf TF: Myeloid surface antigen positive acute lymphoblastic leukemia: Immunophenotypic, ultrastructural, cytogenetic and molecular characteristics. Leukemia 3:777, 1989
13. Guyotat D, Campos L, Shi Z-H, Charrin C, Treille D, Magaud JP, Fiere D: Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 4:664, 1990
14. Lauria F, Raspadori D, Martinelli G, Rondelli D, Ventura MA, Farabegoli F, Tosi P, Testoni N, Visani G, Zaccaria A: Increased expression of myeloid antigen markers in adult acute lymphoblastic leukemia patients: Diagnostic and prognostic implications. Br J Haematol 87:286, 1994
15. Boucheix C, David B, Sebban C, Racadot E, Bené MC, Bernard AM Campos L, Jouault H, Sigaux F, Lepage E, Hervé P, Fière D: Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: An analysis of a prospective trial including 562 tested patients (LALA87). Blood 84:1603, 1994
16. Ludwig W-D, Reiter A, Loeffler H, Goekbuget, Hoelzer D, Riehm H, Thiel E: Immunophenotypic features of childhood and adult acute lymphoblastic leukemia: Experience of the German multicenter trials ALL-BFM and GMALL. Leuk Lymphoma 13:71, 1994
17. Urbano-Ispizua A, Matutes E, Vilamor N, Ribera JM, Feliu E, Montserrat E, Granena A, Vives-Corrons JL, Rozman C: Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukemia. Br J Haematol 75:202, 1990
18. Pui C-H, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J, Crist WM, Behm FG: Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78:1327, 1991
19. Wiersma SD, Ortega J, Sobel E, Wienberg KI: Clinical importance of myeloid antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 324:800, 1991
20. Borowitz MJ, Shuster JJ, Land VJ, Steuber CP, Vitti TJ: Myeloid antigen coexpression in childhood acute lymphoblastic leukemia. N Engl J Med 325:1379, 1991 (correspondence)
21. Pui C-H, Schell MJ, Raimondi SC, Head DR, Rivera GK, Crist WM, Behm FG: Myeloid antigen expression in childhood acute lymphoblastic leukemia N Engl J Med 325:1378, 1991 (correspondence)
22. Cantù-Rajnoldi A, Putti MC, Granchi D, Foà R, Shirò R, Castagni M, Valeggio C, Jankovich M, Miniero R, Paolucci P, Basso G: Co-expression of myeloid antigens in childhood acute lymphoblastic leukemia: Relationship with the stage of differentiation and clinical significance. Br J Hematol 79:40, 1991
23. Kurec AS, Belair P, Stefanu C, Barret DM, Dubowy RL, Davey FR: Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer 67:3081, 1991
24. Fink M-M, Koeller U, Mayer H, Haas OA, Gruemayer-Panzer R, Urban C, Dengg K, Mutz I, Tuechler H, Gattere-Menz I, Knapp W, Gadner H: Prognostic significance of myeloid associated antigen expression on blast cells in children with acute lymphoblastic leukemia. Med Pediatr Oncol 21:340, 1993
25. Uckun FM, Sather HN, Gaynon PS, Arthur DC, Trigg ME, Tubergen DG, Nachman J, Steinherz PG, Sensel MG, Reaman GH: Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 90:28, 1997
26. Van der Does-van der Berg A, Bartram C, Basso G, Benoit YC, Biondi A, Debatin KM, Haas O, Harbott J, Kamps WA, Koeller U, Lampert F, Ludwig W-D, Niemayer C, van Wering ER: Minimal requirements for diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM" Family Cooperative Group. Med Pediatr Oncol 20:497, 1992
27. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollmann B, Henze G. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 199:15l, 1987
28. Conter V, Arico' M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G, Rondelli R, Pession A, Masera G: Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediaterisk lymphoblastic leukemia treated with Berlin-Frankfurt-Munster based invasive chemotherapy. The Associazione Italiana di Ematologia e Oncologia Pediatrica. J Clin Oncol 13:2497, 1995
29. Conter V, Schrappe M, Arico' M, Reiter A, Rizzari C, Doerdelmann M, Valsecchi MG, Zimmermann M, Ludwig D-W, Basso G, Masera G, Riehm H: Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. J Clin Oncol 15:2786, 1997
30. Schrappe M, Reiter A, Sauter S, Ludwig WD, Harbott J, Bender-Gotze C, Dorffel, Dopfer R, Frey E: Concept and interim results of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: The significance of initial therapy response in blood and bone marrow. Klin Padiatr 206:208, 1994
31. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnik HR, Sultan C: The FAB Cooperative Group. The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlation. Br J Haematol 47:553, 1981
32. Basso G, Putti MC, Cantù-Rajnoldi A, Saitta M, Santostasi T, Santoro N, Lippi A, Comelli A, Felici L, Favre C, Russo Mancuso G, Guglielmi C, Paolucci P, Biondi A, Rondelli R, Pession A: The immunophenotype in infant acute lymphoblastic leukemia: Correlation with clinical outcome. An Italian multicenter study (AIEOP). Br J Haematol 81:184, 1981
33. Gale RP, Ben Bassat I: Hybrid acute leukemia. Br J Haematol 65:261, 1987
34. Smith M, Arthur D, Camitta B, Grist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Sharon M, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster R, Simon R, Trigg M, Tuberegn D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18, 1996
35. Pearson ES, Hartley HO: Biometrika Tables for Statisticians (vol 1, ed 3). New York, NY, Cambridge, 1966
36. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
37. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719, 1959
38. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187, 1972
39. Basso G, Rondelli R, Putti MC, Cantu'Rajnoldi A, Granchi D, Cocito MG, Saitta M, Santostasi T, Guglielmi C, Lippi A, Santoro N, Pession A, Arico' M, Biondi A: Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: The experience of the AIEOP Cooperative study. Recent Results Cancer Res 131:298, 1993
40. Lenkei R, Bjork O, Oest A, Biberfield P: Expression of CD 15 as a predictor of relapse in children wih acute lymphoblastic leukemia of the pre-B type. Leuk Res 15:189, 1991
41. Ludwig WD, Bartram CR, Harbott J, Koeller U, Haas OA, Hansen-Hagge T, Heil G, Seibt-Jung H, Teichmann JV, Ritter J, Knapp W, Gadner H, Theil E, Riehm H: Phenotypic and genotypic heterogeneity in infant acute leukemia I. Acute lymphoblastic leukemia. Leukemia 3:431, 1989
42. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM, Masera G, Mandelli F, Canaani E: ALL-1 gene at chromosome 11q23 is consistently altered in acute lymphoblastic leukemia of early infancy. Blood 82:544, 1993
43. Arico' M, Basso G, Mandelli F, Rizzari C, Colella R, Barisone E, Zanesco L, Rondelli R, Pession A, Masera G: Good steroid response in vivo predicts a favourable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica. Cancer 75:1684, 1995
44. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig W-D, Mangioni S, Burci L, Schrappe M, Rierhm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A: Incidence and clinical relevance of TEL/AML l fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571, 1997
45. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeller HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gillland DG, Golub TR: TEL/AML 1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252, 1996
46. Schurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui C-H, Grosveld G, Downing JR: TEL/ AML1 fusion resulting from criptic t(12;21) is the most common genetic lesion in pediatrie ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985, 1995
47. Pinkel D: Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol 14:4, 1996
48. Campana D, Hansen-Hagge TE, Matutes E, Coustan-Smith E, Yokota S, Shetty V, Bartram C, Janossy G: Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukemia. Leukemia 4:620, 1990
49. Campana D, Freitas RO, Coustan-Smith E: Detection of residual leukemia with immunologie methods: Technical developments and clinical implications. Leuk Lymphoma 13:31, 1994
50. Orfao A, Ciudad J, Lopez-Berges MC, Vidriales B, Caballero MD, Valverde B, Gonzales M, San Miguel JF: Acute lymphoblastic leukemia: Detection of minimal residual disease at flow cytometry. Leuk Lymphoma 13:87, 1994
51. Van Dongen JJM, Szczepansky T, de Bruijn MAC, van den Beemd MWM, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJM, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H: Detection of minimal residual disease in acute leukemia patients. Cytokines Mol Ther 2:121, 1996